Introduction
============

Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly population, characterized as chronic and progressive degeneration of photoreceptors, the underlying retinal pigment epithelium (RPE), Bruch's membrane, and possibly, the choriocapillaris in the macula \[[@r1],[@r2]\]. AMD is divided clinically into dry and wet AMD. Patients with dry AMD present with cellular debris (drusen) in or under the retinal pigment epithelium (RPE), irregularities in the pigmentation of the RPE, or geographic atrophy (GA). Patients with exudative or wet AMD are characterized by serous detachment of the RPE or choroidal neovascularization (CNV), or both \[[@r1],[@r2]\]. Advanced AMD, including geographic atrophy or exudative disease, can cause severe vision loss.

It is believed that AMD is a complex disorder caused by the interaction of multiple genetic and environmental risk factors \[[@r3]--[@r7]\]. Identification of AMD related genes has been tremendously successful. Complement pathway genes, including complement factor *H* (*CFH*) \[[@r2],[@r8]--[@r13]\], *C2/CFB* \[[@r14]--[@r16]\], and *C3* \[[@r15]--[@r17]\], have been confirmed by many replication studies. The *LOC387715/HTRA1* gene has also been verified as a major AMD locus in different populations \[[@r18]--[@r24]\]. Recently, SNPs in the serpin peptidase inhibitor, clade G (C1 inhibitor) member 1 (*SERPING1*) gene showed highly significant genotypic association with age-related macular degeneration in two Caucasian populations \[[@r25]\]. Unfortunately, this finding could not be replicated by other studies \[[@r26]--[@r34]\].

To further analyze the association of *SERPING1* and AMD, we investigated the association between SNPs in this gene and AMD in a mainland Han Chinese population.

Methods
=======

Subjects
--------

The Institutional Review Boards of the Sichuan Provincial People's Hospital, Xinhua Hospital of Shanghai Jiao Tong University, and Zhongshan Ophthalmic Center, China approved this study. All subjects provided informed consent before participation in the study. AMD patients and normal age-matched controls, including individuals with a normal eye examination (individuals age 60 years or older with no drusen or RPE changes), were recruited in the ophthalmology clinic at Sichuan Provincial People's Hospital, Xinhua Hospital of Shanghai Jiao Tong University, and Zhongshan Ophthalmic Center, China. All participants went through a standard examination protocol as in the previous description \[[@r19],[@r24],[@r27]\]. Grading was performed using a standard grid classification suggested by the International ARM Epidemiological Study Group for age-related maculopathy (ARM) and the age-related macular degeneration group \[[@r27]\]. All abnormalities in the macula were characterized according to the type, size and number of drusen, and hyperpigmentation or hypopigmentation, as well as AMD stages as defined by AREDS 1--5 stages. Patients with clinical features of AMD and CNV (CNV from other causes was excluded), with or without drusen, were diagnosed as wet AMD patients. Patients with only soft drusen were diagnosed as drusen (dry AMD) patients. In total, 194 wet AMD patients (Eight from Zhongshan Ophthalmic Center, 28 from Xinhua Hospital, 158 from of the Sichuan Provincial People's Hospital), 78 soft drusen patients (all from of the Sichuan Provincial People's Hospital), and 285 normal matched controls (Eight from Zhongshan Ophthalmic Center, 30 from Xinhua Hospital and 247 from of the Sichuan Provincial People's Hospital) were recruited. In the normal matched controls, all individuals underwent an eye exam, no signs of early AMD, such as soft drusen or irregular pigmentations of the RPE in the macular area, were observed. Clinical information about the cases and controls is listed in [Table 1](#t1){ref-type="table"}.

###### Characteristics of amd cases and controls matched for ages and ethnicity.

  **Subject**            **Total number**   **Male**   **Female**   **Average age**
  ---------------------- ------------------ ---------- ------------ -----------------
  All AMD (CNV+drusen)   272                126        146          68.2±9.8
  CNV                    194                90         104          69.4±12.2
  drusen                 78                 36         42           68.7±8.7
  Controls               285                132        153          68.4±7.2

Selection of tag and functional SNPs
------------------------------------

We used the data of the Han Chinese Beijing population in [HapMap3](http://hapmap.ncbi.nlm.nih.gov/) of the international HapMap project and previous studies to select tag SNPs or functional SNPs in *SERPING1* \[[@r26],[@r28]\] for this study. Six SNPs were selected for genotyping, including [rs2511990](http://www.ncbi.nlm.nih.gov/snp?term=rs2511990) upstream of the transcription start site (−2877 bases), [rs1005510](http://www.ncbi.nlm.nih.gov/snp?term=rs1005510) in intron 2, [rs11546660](http://www.ncbi.nlm.nih.gov/snp?term=rs11546660) (A56V) in exon 3, [rs2511989](http://www.ncbi.nlm.nih.gov/snp?term=rs2511989), [rs2511988](http://www.ncbi.nlm.nih.gov/snp?term=rs2511988) in intron 6, and [rs4926](http://www.ncbi.nlm.nih.gov/snp?term=rs4926) (M480V) in exon 8.

Genotyping
----------

Blood from each subject was drawn and collected in an EDTA-containing tube. Genomic DNA was extracted from the blood by a Gentra Puregene Blood DNA kit (Minneapolis, MN). SNP genotyping was performed by the dye terminator-based SNaPshot method (Applied Biosystems, Foster City, CA). SNP analysis was performed on the ABI 3130 genetic analyzer (Applied Biosystems). Genotypes of the SNPs were determined by Genemapper software (Applied Biosystems). All SNPs reported in this manuscript had a genotyping success rate \>96 percent and accuracy as judged by random re-genotyping of 10 percent of the samples in the subject group. Six SNPs in *SERPING1* were genotyped. The PCR and SNaPshot primers are listed in [Table 2](#t2){ref-type="table"}.

###### Genotyping primers.

  **SNP**                                                       **PCR Primer Forward**    **Snapshot Primer**
  ------------------------------------------------------------- ------------------------- ------------------------------------------------
  [rs2511989](http://www.ncbi.nlm.nih.gov/snp?term=rs2511989)   F: TTCACAGCCTACCTTTCC     CCCTGGGTTTAATACAGGGGTTGTCAACTC
                                                                R: CAGCCTCAATCATAATACCA   
  [rs2511990](http://www.ncbi.nlm.nih.gov/snp?term=rs2511990)   F: AAGCTGGAGCTGAAACTG     GTTCTCTTCCCACTGGGAGCAGGTCTAGGATTTCTC
                                                                R: GGAAGAGGGATTCTGTGG     
  [rs1005510](http://www.ncbi.nlm.nih.gov/snp?term=rs1005510)   F: TTCTTACTACGAGGCACA     ATGTGGAAAATGTCCTGTACAAGAGAGTAATTTCTGACAGTGC
                                                                R: TAAATCAAGGAGCACAAG     
  [rs2244169](http://www.ncbi.nlm.nih.gov/snp?term=rs2244169)   F: TGGCGTGAACCCTGGAGA     CAGCCAGAAAAGTTTTACAAAGCACGTATATGAC
                                                                R: AGGTGGGAGGATTGCTTG     
  [rs2511988](http://www.ncbi.nlm.nih.gov/snp?term=rs2511988)   F: AGTGGGCTGGAACTTGGA     ATTGTGGGAGAGCTGCAGCTGCCCCACCTAGAAAATAAGAGATGCA
                                                                R: GCATTGTGACAGAGGGTG     

Haplotype analysis
------------------

Haplotype analysis was performed using [Haploview 4.0](http://www.broadinstitute.org/haploview/haploview). We performed the haplotype analysis following the instructions from the [Broad Institute](http://www.broadinstitute.org/mpg/haploview). If the genotype was not available, the genotype was set as 0.

Statistical analysis
--------------------

Hardy--Weinberg equilibrium (HWE) for each SNP polymorphism was tested by the χ^2^ test with df=1. P values of the SNPs were calculated using an additive model. Haplotype frequencies between cases and controls were compared by χ^2^ analysis. The unadjusted odds ratios of the alleles and genotypes were estimated by the χ^2^ test. All statistical analyses were performed using the software SPSS, (SPSS, Chicago, IL) version 10.0 \[[@r18]--[@r24]\].

Results
=======

Single nucleotide polymorphism analysis
---------------------------------------

All six SNPs selected were successfully genotyped and all of these SNPs were within HWE in both case (p\>0.001, [Table 3](#t3){ref-type="table"}) and control groups (p\>0.05, [Table 3](#t3){ref-type="table"}). The SNP frequencies in this study were similar to those of Han Chinese Beijing (HCB) available in HapMap3 in the International [HapMap](http://hapmap.jst.go.jp/) Project. None of the six SNPs showed significant association with AMD or subphenotypes of AMD including wet AMD or soft drusen, which are landmarks of early AMD even before a stringent Bonferroni correction (p≥0.05, [Table 3](#t3){ref-type="table"}). SNP [rs2511989](http://www.ncbi.nlm.nih.gov/snp?term=rs2511989) was reported to be the most significant association of SNP in the *SERPING1* gene with AMD in previous studies \[[@r25]\]. Although [rs2511989](http://www.ncbi.nlm.nih.gov/snp?term=rs2511989) showed high polymorphism, no association between this SNP and AMD was observed in the Chinese population (p=0.76 for all AMD; p=0.61 for CNV AMD; p=0.77 for soft drusen).

###### Association between subphenotypes of AMD ANS SNPS in *SERPING1* in the Han Chinese subject group.

  **SNP (risk allele)**                                                **Physical location (Chr.11)\***   **Phenotype**   **Genotype count**   **Allele frequency**   **HWE**   **Trend p-value**           
  -------------------------------------------------------------------- ---------------------------------- --------------- -------------------- ---------------------- --------- ------------------- ------- ------
  [rs2511990](http://www.ncbi.nlm.nih.gov/snp?term=rs2511990)  (T)     57119284                           CVN+Drusen      CC:211               CT:50                  TT:10     0.13                0.003   0.59
                                                                                                          CNV             CC:148               CT:35                  TT:10     0.14                0.002   0.3
                                                                                                          Drusen          CC:63                CT:15                  TT:0      0.1                 0.643   0.47
                                                                                                          Control         CC:226               CT:51                  TT:8      0.12                0.068   
  [rs1005510](http://www.ncbi.nlm.nih.gov/snp?term=rs1005510)  (G)     57123798                           CVN+Drusen      AA:140               AG:117                 GG:15     0.27                0.135   0.44
                                                                                                          CNV             AA:101               AG:81                  GG:12     0.27                0.724   0.49
                                                                                                          Drusen          AA:39                AG:36                  GG:3      0.27                0.312   0.58
                                                                                                          Control         AA:134               AG:131                 GG:16     0.29                0.087   
  [rs11546660](http://www.ncbi.nlm.nih.gov/snp?term=rs11546660)  (C)   57124043                           CVN+Drusen      TT:249               CT:21                  CC:0      0.04                0.506   0.05
                                                                                                          CNV             TT:178               CT:16                  CC:0      0.04                0.836   0.1
                                                                                                          Drusen          TT:71                CT:5                   CC:0      0.03                0.957   0.13
                                                                                                          Control         TT:245               CT:35                  CC:1      0.07                0.978   
  [rs2511989](http://www.ncbi.nlm.nih.gov/snp?term=rs2511989)  (A)     57134901                           CVN+Drusen      GG:198               AG:57                  AA:5      0.13                0.706   0.76
                                                                                                          CNV             GG:147               AG:42                  AA:5      0.13                0.644   0.61
                                                                                                          Drusen          GG:51                AG:15                  AA:0      0.08                0.298   0.77
                                                                                                          Control         GG:215               AG:63                  AA:3      0.12                0.791   
  [rs2511988](http://www.ncbi.nlm.nih.gov/snp?term=rs2511988)  (C)     57135746                           CVN+Drusen      TT:155               CT:103                 CC:14     0.25                0.557   0.99
                                                                                                          CNV             TT:110               CT:73                  CC:11     0.24                0.971   0.89
                                                                                                          Drusen          TT:45                CT:30                  CC:3      0.23                0.763   0.77
                                                                                                          Control         TT:155               CT:118                 CC:9      0.24                0.025   
  [rs4926](http://www.ncbi.nlm.nih.gov/snp?term=rs4926)  (A)           57138565                           CVN+Drusen      GG:201               AG:65                  AA:6      0.14                0.784   0.43
                                                                                                          CNV             GG:147               AG:42                  AA:5      0.13                0.644   0.7
                                                                                                          Drusen          GG:54                AG:23                  AA:1      0.16                0.689   0.25
                                                                                                          Control         GG:209               AG:63                  AA:3      0.13                0.766   

Haplotype association analysis
------------------------------

We then performed haplotype analysis using Haploview 4.0, and 14, 15, and 14 haplotypes were observed in the AMD-control, wet AMD-control, and drusen-control groups, respectively. We found that haplotype TGTGCG and haplotype CGCGCG were shown to have a significant difference between both AMD-control (p=0.0064, p=0.006, respectively, [Table 4](#t4){ref-type="table"}) and wet AMD-control groups (p=0.0042, p=0.025, respectively, [Table 4](#t4){ref-type="table"}). The haplotype CGTGCG was shown to have a significant difference between both AMD-control (p=0.0102, [Table 4](#t4){ref-type="table"}) and drusen-control (p=0.032, [Table 4](#t4){ref-type="table"}). In addition, the haplotype CGTGTA was shown to have a significant difference between wet AMD and controls (p=0.026, [Table 4](#t4){ref-type="table"}). But none of the haplotypes were shown to have a significant difference between cases and controls (p\>0.05, [Table 4](#t4){ref-type="table"}) after a stringent Bonferroni correction. On the other hand, the haplotype CGTGCA was shown to be significantly associated with soft drusen in our subject group (p=7.87x10^−5^, [Table 4](#t4){ref-type="table"}) with frequencies of 0.11 in cases and 0.03 in controls, even after a stringent Bonferroni correction (p=0.0011, [Table 4](#t4){ref-type="table"}). This haplotype conferred a 3.72-fold (95% CI: 1.83--7.54) increased likelihood of dry AMD ([Table 4](#t4){ref-type="table"}). Additionally, the haplotype CGTACA was also shown to have a significant difference between both all AMD-control and wet AMD-control groups (p\<0.05, [Table 4](#t4){ref-type="table"}) after a stringent Bonferroni correction. However, the frequency of this haplotype was low and it was absent in the controls.

###### *SERPING1* haplotype association with AMD in the Han Chinese subject group.

  **Type of AMD**   **Haplotype**   **Frequency**   **Haplotype association (p value)**   **Bufferoni correction**   **Odds ratio (95% CI)**   
  ----------------- --------------- --------------- ------------------------------------- -------------------------- ------------------------- -------------------
  All AMD           H1:CATGTG       0.63            0.57                                  0.0609                                                
                    H2:CGTGTG       0.04            0.06                                  0.1091                                                
                    H3:TGTGCG       0.06            0.02                                  0.0064                     0.0900                     
                    H4:TGTACG       0.03            0.04                                  0.3301                                                
                    H5:CGTGCA       0.04            0.03                                  0.2641                                                
                    H6:CGTGCG       0.02            0.05                                  0.0102                     0.1428                     
                    H7:CATGTA       0.02            0.03                                  0.4105                                                
                    H8:CATATG       0.02            0.03                                  0.5689                                                
                    H9:TATGTG       0.02            0.01                                  0.3679                                                
                    H10:CGCGCA      0.02            0.01                                  0.5900                                                
                    H11:CGTACA      0.03            0.00                                  0.0008                     0.0112                     
                    H12:CGTACG      0.01            0.02                                  0.4070                                                
                    H13:CGTGTA      0.01            0.02                                  0.0628                                                
                    H14:CGCGCG      0.00            0.02                                  0.0060                     0.0840                     
  Wet AMD           H1:CATGTG       0.63            0.57                                  0.0717                                                
                    H2:CGTGTG       0.03            0.06                                  0.0946                                                
                    H3:TGTACG       0.04            0.04                                  0.7668                                                
                    H4:TGTGCG       0.06            0.02                                  0.0042                     0.0630                     
                    H5:CGTGCG       0.02            0.05                                  0.0620                                                
                    H6:CATGTA       0.03            0.03                                  0.6366                                                
                    H7:CGTGCA       0.02            0.03                                  0.5447                                                
                    H8:CATATG       0.02            0.03                                  0.2741                                                
                    H9:CGCGCA       0.02            0.01                                  0.5848                                                
                    H10:TATGTG      0.02            0.01                                  0.3616                                                
                    H11:CGTACG      0.01            0.02                                  0.6028                                                
                    H12:CGCGCG      0.00            0.02                                  0.0256                     0.3840                     
                    H13:CGTACA      0.03            0.00                                  0.0003                     0.0045                     
                    H14:CATGCG      0.01            0.01                                  0.3513                                                
                    H15:CGTGTA      0.00            0.02                                  0.0263                     0.3950                     
  Drusen AMD        H1:CATGTG       0.62            0.57                                  0.2702                                                
                    H2:CGTGTG       0.04            0.06                                  0.5894                                                
                    H3:CGTGCA       0.11            0.03                                  7.87E-05                   1.10E-03                  3.72 (1.83--7.54)
                    H4:CGTGCG       0.01            0.05                                  0.0317                     0.4438                     
                    H5:TGTACG       0.01            0.04                                  0.0909                                                
                    H6:CATATG       0.04            0.03                                  0.6489                                                
                    H7:TGTGCG       0.05            0.02                                  0.1275                                                
                    H8:CATGTA       0.02            0.03                                  0.3929                                                
                    H9:CGTGTA       0.01            0.02                                  0.6998                                                
                    H10:CGCGCG      0.00            0.02                                  0.0894                                                
                    H11:TATGTG      0.02            0.01                                  0.3297                                                
                    H12:CGCGCA      0.01            0.01                                  0.8976                                                
                    H13:CGTACG      0.01            0.02                                  0.4630                                                
                    H14:CATGCG      0.00            0.01                                  0.2656                                                

Discussion
==========

Although genes in complement pathways, including *CFH*, *C2/BF*, and *C3* \[[@r2],[@r8]--[@r17]\] and chr.10q26 (*LOC387715/HTRA1*) \[[@r18]--[@r24]\], have been identified as related to AMD, these loci could not explain all genetic contributions to AMD, suggesting that additional genetic variants related to AMD have not yet been found. Based on the candidate gene approach, Ennis et al. \[[@r25]\] reported that SNPs in *SERPING1* were significantly associated with AMD in two Caucasian populations. Additional evidence for *SERPING1* involving AMD includes: 1) *SERPING1* gene encoding C1INH plays an important role in complement pathways, which have been confirmed to participate in the pathogenesis of AMD; and 2) *SERPING1* was expressed in both retinal and RPE-choroid layers in RT--PCR and immunofluorescence studies \[[@r25],[@r29]\]. AMD affection status was correlated with increased abundance of choroidal C1INH \[[@r29]\]. Complement activation pathways include lectin, classical and alternative pathways. *SERPING1* encodes C1INH, an inhibitor of the classical and lectin pathways of complement activation. The classical complement pathway is initiated by the C1 complex, which comprises a C1q hexamer complex with a zymogenic (C1r)~2~-(C1s) ~2~). SERPING1 irreversibly inhibits C1r and C1s, MASP-1 (mannan-binding lectin serine peptidase 1), and MASP-2 (mannan-binding lectin serine peptidase 2, the C1s ortholog in the lectin pathway), as well as modulating the complement activation through inhibition unrelated to proteases \[[@r30]--[@r33]\]. However, Park et al. \[[@r26]\] were unable to replicate the association between the genetic variation in *SERPING1* and AMD in two large and well characterized Caucasian subject groups, and Allikmets et al. \[[@r34]\] were also unable to replicate the association between [rs2511989](http://www.ncbi.nlm.nih.gov/snp?term=rs2511989) in *SERPING1* and AMD. Additional replication studies, especially of a different ethnicity, are important to determine if *SERPING1* is really associated with AMD. None of the six SNPs showed significant association with AMD and none of the major haplotypes were observed to be significantly associated with AMD or choroid neovascularization AMD (CNV) after a stringent Bonferroni correction in our study, suggesting that *SERPING1* may not be related to AMD in the Han Chinese population. In the haplotype analysis, none of the SNPs tagged the significant haplotypes. Because half of samples' genotype data for [rs11546660](http://www.ncbi.nlm.nih.gov/snp?term=rs11546660) and [rs4926](http://www.ncbi.nlm.nih.gov/snp?term=rs4926) was not available in the HapMap3 for the Chinese, we cannot compare the haplotype frequencies to those in the HapMap. Although four haplotypes including TGTGCG, CGCGCG, CGTGCG, and CGTGTA were shown to have significant associations with different subphenotypes of AMD, anymore after a stringent Bonferroni correction, the significant associations no longer existed, suggesting that these haplotypes were not specifically associated with AMD. Since the haplotype CGTACA was rare in all AMD (3%) and wet groups (3%), and absent in the drusen group and controls, we think that the significant association between this haplotype and AMD is not reliable. The haplotype CGTGCA was shown to be significantly associated with soft drusen in the subject group even after a stringent Bonferroni correction (p=0.0011, [Table 4](#t4){ref-type="table"}). Further replication studies are needed to clarify the current situation because of the limited number of soft drusen samples in this study.

We thank the participating AMD patients and their families. The authors acknowledge the following grant support (to Z. Yang): Department of Science and Technology of Sichuan Province (04JY029--045, 05ZQ026--018); Natural Science Foundation of China (30671182, 30771220).

[^1]: The first four authors contributed equally to this work.
